The National Coordinating Committee on Therapeutic Goods (NCCTG) was established by Order of the Federal Executive Council on 17 March 1971. The 1971 Order was revoked in October 1986 to facilitate the establishment of NCCTG as a committee of the Australian Health Ministers' Advisory Council (AHMAC).

The NCCTG was abolished in 2013.

NCCTG terms of reference

The Terms of Reference of the NCCTG were:

1. To develop, implement and maintain a uniform national approach to the regulations and controls over therapeutic goods and chemicals used by the public
2. To contribute to projects relevant to the development of uniform regulations and controls over therapeutic goods and chemicals
3. To share knowledge on matters relevant to the regulation of therapeutic goods and chemicals
4. To provide policy guidance on amending the Poisons Standard to decision-makers and advisory committees (the Advisory Committee on Medicines Scheduling and the Advisory Committee on Chemicals Scheduling)
5. To consider and report to the Clinical, Technical and Ethical Principal Committee (CTEPC) on any matter referred to the NCCTG by CTEPC
6. To report and make recommendations to the Australian Health Ministers' Advisory Council (through CTEPC) on agreed principles and desired outcomes of the regulation of therapeutic goods and chemicals, including the specific health issues related to people of Aboriginal and Torres Strait Islander origin.